Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 784

1.

Selegiline: a molecule with innovative potential.

Tábi T, Vécsei L, Youdim MB, Riederer P, Szökő É.

J Neural Transm (Vienna). 2019 Sep 27. doi: 10.1007/s00702-019-02082-0. [Epub ahead of print] Review.

PMID:
31562557
2.

Anxiety and Stress - Translational Perspectives.

Riederer P.

J Neural Transm (Vienna). 2019 Sep;126(9):1115. doi: 10.1007/s00702-019-02063-3. No abstract available.

PMID:
31422464
3.

[Erratum to: Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP].

Unterecker S, Hefner G, Baumann P, Gründer G, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Haen E, Havemann-Reinecke U, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zernig G, Zurek G, Hiemke C.

Nervenarzt. 2019 Sep;90(9):958-960. doi: 10.1007/s00115-019-0766-7. German. No abstract available.

PMID:
31309271
4.

α-Synuclein in Parkinson's disease: causal or bystander?

Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C, Jost W, Krüger R, Müller T, Reichmann H, Rieß O, Storch A, Strobel S, van Eimeren T, Völker HU, Winkler J, Winklhofer KF, Wüllner U, Zunke F, Monoranu CM.

J Neural Transm (Vienna). 2019 Jul;126(7):815-840. doi: 10.1007/s00702-019-02025-9. Epub 2019 Jun 25. Review.

PMID:
31240402
5.

Melanin and Neuromelanin Fluorescence Studies Focusing on Parkinson's Disease and Its Inherent Risk for Melanoma.

Leupold D, Szyc L, Stankovic G, Strobel S, Völker HU, Fleck U, Müller T, Scholz M, Riederer P, Monoranu CM.

Cells. 2019 Jun 15;8(6). pii: E592. doi: 10.3390/cells8060592.

6.

Quality and parameter control of X-ray absorption gratings by angular X-ray transmission.

Gustschin N, Gustschin A, Meyer P, Viermetz M, Riederer P, Herzen J, Mohr J, Pfeiffer F.

Opt Express. 2019 May 27;27(11):15943-15955. doi: 10.1364/OE.27.015943.

PMID:
31163783
7.

Journal of Neural Transmission: a scientific journal devoted since 1950 to the translation of neuroscience into clinical practice.

Riederer P, Sillaber A, Solomon N, Hirsch E, Riederer C.

J Neural Transm (Vienna). 2019 Apr;126(4):359-365. doi: 10.1007/s00702-019-01995-0. No abstract available.

8.

Guidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity - a consensus of the Biomarkers Task Force from the WFSBP.

Andreazza AC, Laksono I, Fernandes BS, Toben C, Lewczuk P, Riederer P, Kennedy SH, Kapogiannis D, Thibaut F, Gerlach M, Gallo C, Kim YK, Grünblatt E, Yatham L, Berk M, Baune BT.

World J Biol Psychiatry. 2019 Jun;20(5):340-351. doi: 10.1080/15622975.2019.1574024. Epub 2019 Mar 25.

PMID:
30907211
9.

Cognitive, behavioral and metabolic effects of oral galactose treatment in the transgenic Tg2576 mice.

Babic Perhoc A, Osmanovic Barilar J, Knezovic A, Farkas V, Bagaric R, Svarc A, Grünblatt E, Riederer P, Salkovic-Petrisic M.

Neuropharmacology. 2019 Apr;148:50-67. doi: 10.1016/j.neuropharm.2018.12.018. Epub 2018 Dec 17.

PMID:
30571958
10.

Astrocyte- and Microglia-Specific Mitochondrial DNA Deletions Levels in Sporadic Alzheimer's Disease.

Strobel S, Grünblatt E, Heinsen H, Riederer P, Espach T, Meder M, Monoranu CM.

J Alzheimers Dis. 2019;67(1):149-157. doi: 10.3233/JAD-180661.

PMID:
30475765
11.

[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP].

Unterecker S, Hefner G, Baumann P, Gründer G, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Haen E, Havemann-Reinecke U, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zernig G, Zurek G, Hiemke C.

Nervenarzt. 2019 May;90(5):463-471. doi: 10.1007/s00115-018-0643-9. Review. German. Erratum in: Nervenarzt. 2019 Jul 15;:.

PMID:
30446893
12.

Introduction to the special issue on monoamine oxidase A and B: eternally enigmatic isoenzymes.

Shih JC, Riederer P, Maruyama W, Naoi M.

J Neural Transm (Vienna). 2018 Nov;125(11):1517-1518. doi: 10.1007/s00702-018-1920-2. Epub 2018 Sep 26. No abstract available.

13.

Streptozotocin Impairs Proliferation and Differentiation of Adult Hippocampal Neural Stem Cells in Vitro-Correlation With Alterations in the Expression of Proteins Associated With the Insulin System.

Sun P, Ortega G, Tan Y, Hua Q, Riederer PF, Deckert J, Schmitt-Böhrer AG.

Front Aging Neurosci. 2018 May 18;10:145. doi: 10.3389/fnagi.2018.00145. eCollection 2018.

14.

Lateralisation in Parkinson disease.

Riederer P, Jellinger KA, Kolber P, Hipp G, Sian-Hülsmann J, Krüger R.

Cell Tissue Res. 2018 Jul;373(1):297-312. doi: 10.1007/s00441-018-2832-z. Epub 2018 Apr 14. Review.

PMID:
29656343
15.

Monoamine oxidase-B inhibitors in the treatment of Parkinson's disease: clinical-pharmacological aspects.

Riederer P, Müller T.

J Neural Transm (Vienna). 2018 Nov;125(11):1751-1757. doi: 10.1007/s00702-018-1876-2. Epub 2018 Mar 22. Review.

PMID:
29569037
16.

Glucagon-like peptide-1 mediates effects of oral galactose in streptozotocin-induced rat model of sporadic Alzheimer's disease.

Knezovic A, Osmanovic Barilar J, Babic A, Bagaric R, Farkas V, Riederer P, Salkovic-Petrisic M.

Neuropharmacology. 2018 Jun;135:48-62. doi: 10.1016/j.neuropharm.2018.02.027. Epub 2018 Feb 28.

PMID:
29501615
17.

Neurochemical markers as potential indicators of postmortem tissue quality.

Sian-Hülsmann J, Monoranu CM, Grünblatt E, Riederer P.

Handb Clin Neurol. 2018;150:119-127. doi: 10.1016/B978-0-444-63639-3.00009-8. Review.

PMID:
29496135
18.

TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>.

Schoretsanitis G, Paulzen M, Unterecker S, Schwarz M, Conca A, Zernig G, Gründer G, Haen E, Baumann P, Bergemann N, Clement HW, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud-Sirot E, Laux G, Messer T, Mössner R, Müller MJ, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Silva Gracia M, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zurek G, Hiemke C.

World J Biol Psychiatry. 2018 Apr;19(3):162-174. doi: 10.1080/15622975.2018.1439595. Epub 2018 Mar 1. Review.

PMID:
29493375
19.

Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease.

Szökő É, Tábi T, Riederer P, Vécsei L, Magyar K.

J Neural Transm (Vienna). 2018 Nov;125(11):1735-1749. doi: 10.1007/s00702-018-1853-9. Epub 2018 Feb 7. Review.

PMID:
29417334
20.

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.

Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P.

Pharmacopsychiatry. 2018 Jan;51(1-02):e1. doi: 10.1055/s-0037-1600991. Epub 2018 Feb 1. No abstract available.

PMID:
29390205
21.

Toshiharu (Toshi) Nagatsu: an appreciation.

Riederer P, Takahashi R, Hattori N.

J Neural Transm (Vienna). 2018 Jan;125(1):1-2. doi: 10.1007/s00702-017-1826-4. No abstract available.

PMID:
29260324
22.

Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson's Disease Substantia Nigra.

Grünblatt E, Ruder J, Monoranu CM, Riederer P, Youdim MB, Mandel SA.

Neurotox Res. 2018 Apr;33(3):560-568. doi: 10.1007/s12640-017-9843-5. Epub 2017 Dec 7.

PMID:
29218503
23.

Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3) levels in post-mortem brain tissue from patients with depression compared to healthy individuals - a proof of concept study.

Sheldrick A, Camara S, Ilieva M, Riederer P, Michel TM.

Eur Psychiatry. 2017 Oct;46:65-71. doi: 10.1016/j.eurpsy.2017.06.009. Epub 2017 Jul 11.

PMID:
29102768
24.

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJ, Jellinger KA, Engelborghs S, Ramirez A, Parnetti L, Jack CR Jr, Teunissen CE, Hampel H, Lleó A, Jessen F, Glodzik L, de Leon MJ, Fagan AM, Molinuevo JL, Jansen WJ, Winblad B, Shaw LM, Andreasson U, Otto M, Mollenhauer B, Wiltfang J, Turner MR, Zerr I, Handels R, Thompson AG, Johansson G, Ermann N, Trojanowski JQ, Karaca I, Wagner H, Oeckl P, van Waalwijk van Doorn L, Bjerke M, Kapogiannis D, Kuiperij HB, Farotti L, Li Y, Gordon BA, Epelbaum S, Vos SJB, Klijn CJM, Van Nostrand WE, Minguillon C, Schmitz M, Gallo C, Lopez Mato A, Thibaut F, Lista S, Alcolea D, Zetterberg H, Blennow K, Kornhuber J; Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut.

World J Biol Psychiatry. 2018 Jun;19(4):244-328. doi: 10.1080/15622975.2017.1375556. Epub 2017 Oct 27. Review.

25.

Explorative results from multistep screening for potential genetic risk loci of Alzheimer's disease in the longitudinal VITA study cohort.

Scholz CJ, Weber H, Jungwirth S, Danielczyk W, Reif A, Tragl KH, Fischer P, Riederer P, Deckert J, Grünblatt E.

J Neural Transm (Vienna). 2018 Jan;125(1):77-87. doi: 10.1007/s00702-017-1796-6. Epub 2017 Oct 12.

PMID:
29027019
27.

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.

Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P.

Pharmacopsychiatry. 2018 Jan;51(1-02):9-62. doi: 10.1055/s-0043-116492. Epub 2017 Sep 14. Review. Erratum in: Pharmacopsychiatry. 2018 Jan;51(1-02):e1.

28.

The diabetic brain and cognition.

Riederer P, Korczyn AD, Ali SS, Bajenaru O, Choi MS, Chopp M, Dermanovic-Dobrota V, Grünblatt E, Jellinger KA, Kamal MA, Kamal W, Leszek J, Sheldrick-Michel TM, Mushtaq G, Meglic B, Natovich R, Pirtosek Z, Rakusa M, Salkovic-Petrisic M, Schmidt R, Schmitt A, Sridhar GR, Vécsei L, Wojszel ZB, Yaman H, Zhang ZG, Cukierman-Yaffe T.

J Neural Transm (Vienna). 2017 Nov;124(11):1431-1454. doi: 10.1007/s00702-017-1763-2. Epub 2017 Aug 1. Review.

PMID:
28766040
29.

The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitro.

Bartl J, Palazzesi F, Parrinello M, Hommers L, Riederer P, Walitza S, Grünblatt E.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):281-288. doi: 10.1016/j.pnpbp.2017.07.002. Epub 2017 Jul 8.

PMID:
28690202
30.

Determination of Monoamine Oxidase A and B Activity in Long-Term Treated Patients With Parkinson Disease.

Müller T, Riederer P, Grünblatt E.

Clin Neuropharmacol. 2017 Sep/Oct;40(5):208-211. doi: 10.1097/WNF.0000000000000233.

31.

[Epidemiology of Parkinson's Disease and Current Concepts of Outpatient Care in Germany].

Tönges L, Ehret R, Lorrain M, Riederer P, Müngersdorf M.

Fortschr Neurol Psychiatr. 2017 Jun;85(6):329-335. doi: 10.1055/s-0043-103275. Epub 2017 Jun 23. Review. German.

PMID:
28645125
32.

Prof. Dr. Kurt Jellinger: an appreciation.

Riederer P.

J Neural Transm (Vienna). 2017 Jun;124(6):669-670. doi: 10.1007/s00702-017-1733-8. No abstract available.

PMID:
28508292
33.

Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer's disease?

Knezovic A, Loncar A, Homolak J, Smailovic U, Osmanovic Barilar J, Ganoci L, Bozina N, Riederer P, Salkovic-Petrisic M.

J Neural Transm (Vienna). 2017 Jun;124(6):695-708. doi: 10.1007/s00702-017-1727-6. Epub 2017 May 3.

PMID:
28470423
34.

Classification of advanced stages of Parkinson's disease: translation into stratified treatments.

Krüger R, Klucken J, Weiss D, Tönges L, Kolber P, Unterecker S, Lorrain M, Baas H, Müller T, Riederer P.

J Neural Transm (Vienna). 2017 Aug;124(8):1015-1027. doi: 10.1007/s00702-017-1707-x. Epub 2017 Mar 24. Review.

35.

Simultaneous determination of MAO-A and -B activity following first time intake of an irreversible MAO-B inhibitor in patients with Parkinson's disease.

Müller T, Riederer P, Grünblatt E.

J Neural Transm (Vienna). 2017 Jun;124(6):745-748. doi: 10.1007/s00702-017-1705-z. Epub 2017 Mar 15.

PMID:
28299453
36.

Use of monoamine oxidase inhibitors in chronic neurodegeneration.

Riederer P, Müller T.

Expert Opin Drug Metab Toxicol. 2017 Feb;13(2):233-240. doi: 10.1080/17425255.2017.1273901. Epub 2017 Jan 1. Review.

PMID:
27998194
37.

The dopamine-related polymorphisms BDNF, COMT, DRD2, DRD3, and DRD4 are not linked with changes in CSF dopamine levels and frequency of HIV infection.

Horn A, Scheller C, du Plessis S, Burger R, Arendt G, Joska J, Sopper S, Maschke CM, Obermann M, Husstedt IW, Hain J, Riederer P, Koutsilieri E; German Competence Network HIV/AIDS.

J Neural Transm (Vienna). 2017 Apr;124(4):501-509. doi: 10.1007/s00702-016-1659-6. Epub 2016 Dec 1.

PMID:
27909828
38.

Proteomic characterization of neuromelanin granules isolated from human substantia nigra by laser-microdissection.

Plum S, Steinbach S, Attems J, Keers S, Riederer P, Gerlach M, May C, Marcus K.

Sci Rep. 2016 Nov 14;6:37139. doi: 10.1038/srep37139.

39.

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms.

Schmitt A, Martins-de-Souza D, Akbarian S, Cassoli JS, Ehrenreich H, Fischer A, Fonteh A, Gattaz WF, Gawlik M, Gerlach M, Grünblatt E, Halene T, Hasan A, Hashimoto K, Kim YK, Kirchner SK, Kornhuber J, Kraus TFJ, Malchow B, Nascimento JM, Rossner M, Schwarz M, Steiner J, Talib L, Thibaut F, Riederer P, Falkai P; Members of the WFSBP Task Force on Biological Markers.

World J Biol Psychiatry. 2017 Aug;18(5):330-356. doi: 10.1080/15622975.2016.1224929. Epub 2016 Oct 26. Review.

PMID:
27782767
40.

Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Bandelow B, Baldwin D, Abelli M, Bolea-Alamanac B, Bourin M, Chamberlain SR, Cinosi E, Davies S, Domschke K, Fineberg N, Grünblatt E, Jarema M, Kim YK, Maron E, Masdrakis V, Mikova O, Nutt D, Pallanti S, Pini S, Ströhle A, Thibaut F, Vaghi MM, Won E, Wedekind D, Wichniak A, Woolley J, Zwanzger P, Riederer P.

World J Biol Psychiatry. 2017 Apr;18(3):162-214. doi: 10.1080/15622975.2016.1190867. Epub 2016 Jul 15. Review.

41.

Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics.

Bandelow B, Baldwin D, Abelli M, Altamura C, Dell'Osso B, Domschke K, Fineberg NA, Grünblatt E, Jarema M, Maron E, Nutt D, Pini S, Vaghi MM, Wichniak A, Zai G, Riederer P.

World J Biol Psychiatry. 2016 Aug;17(5):321-65. doi: 10.1080/15622975.2016.1181783. Epub 2016 Jul 12.

PMID:
27403679
42.

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics.

Schmitt A, Rujescu D, Gawlik M, Hasan A, Hashimoto K, Iceta S, Jarema M, Kambeitz J, Kasper S, Keeser D, Kornhuber J, Koutsouleris N, Lanzenberger R, Malchow B, Saoud M, Spies M, Stöber G, Thibaut F, Riederer P, Falkai P; WFSBP Task Force on Biological Markers.

World J Biol Psychiatry. 2016 Sep;17(6):406-28. doi: 10.1080/15622975.2016.1183043. Epub 2016 Jun 17.

PMID:
27311987
43.

Effects of botulinum toxin type A facial injection on monoamines and their metabolites in sensory, limbic and motor brain regions in rats.

Ibragić S, Matak I, Dračić A, Smajlović A, Muminović M, Proft F, Sofić E, Lacković Z, Riederer P.

Neurosci Lett. 2016 Mar 23;617:213-7. doi: 10.1016/j.neulet.2016.02.020. Epub 2016 Feb 11.

PMID:
26876447
44.

Laboratory assessments in the course of Parkinson's disease: a clinician's perspective.

Müller T, Baas H, Kassubek J, Riederer P, Urban PP, Schrader C, Reichmann H, Woitalla D, Gerlach M.

J Neural Transm (Vienna). 2016 Jan;123(1):65-71. doi: 10.1007/s00702-015-1481-6. Epub 2015 Nov 14. Review.

PMID:
26573521
45.

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part I: Neurophysiology.

Thibaut F, Boutros NN, Jarema M, Oranje B, Hasan A, Daskalakis ZJ, Wichniak A, Schmitt A, Riederer P, Falkai P; WFSBP Task Force on Biological Markers.

World J Biol Psychiatry. 2015;16(5):280-90. doi: 10.3109/15622975.2015.1050061. Review.

PMID:
26213111
46.

Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.

Salkovic-Petrisic M, Knezovic A, Osmanovic-Barilar J, Smailovic U, Trkulja V, Riederer P, Amit T, Mandel S, Youdim MB.

Life Sci. 2015 Sep 1;136:108-19. doi: 10.1016/j.lfs.2015.06.026. Epub 2015 Jul 6.

PMID:
26159898
47.

Long-Term Effects of Intracerebroventricular Streptozotocin Treatment on Adult Neurogenesis in the Rat Hippocampus.

Sun P, Knezovic A, Parlak M, Cuber J, Karabeg MM, Deckert J, Riederer P, Hua Q, Salkovic-Petrisic M, Schmitt AG.

Curr Alzheimer Res. 2015;12(8):772-84.

PMID:
26159196
48.

Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction.

Grünblatt E, Bartl J, Iuhos DI, Knezovic A, Trkulja V, Riederer P, Walitza S, Salkovic-Petrisic M.

J Mol Psychiatry. 2015 Jun 4;3(1):6. doi: 10.1186/s40303-015-0012-6. eCollection 2015.

49.

Human Genetic Diseases.

Deng H, Riederer P, Deng HX, Le W, Xiong W, Guo Y.

Biomed Res Int. 2015;2015:315216. doi: 10.1155/2015/315216. Epub 2015 May 20. No abstract available.

50.

Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.

Knezovic A, Osmanovic-Barilar J, Curlin M, Hof PR, Simic G, Riederer P, Salkovic-Petrisic M.

J Neural Transm (Vienna). 2015 Apr;122(4):577-92. doi: 10.1007/s00702-015-1394-4. Epub 2015 Mar 26.

PMID:
25808906

Supplemental Content

Loading ...
Support Center